BioTelemetry, Inc. BEAT Income Statement

Biotelemetry, inc. (BEAT)

Income statement / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Sep'12	Jun'12
Revenue:
Healthcare
-	-	-	-	-	-	-	-	-	-	-	-	167,026	-	162,749	158,041	152,131	145,963	141,985	140,960	138,865	133,178	124,608	114,225	104,975	100,386	97,215	97,453	0	0	0
Research
-	-	-	-	-	-	-	-	-	-	-	-	36,496	-	29,209	24,273	21,818	21,853	21,234	20,528	20,332	19,744	19,106	20,290	20,297	20,329	18,306	12,823	0	0	0
Other
-	-	-	-	-	-	-	-	-	-	-	-	0	-	9,191	9,272	9,769	10,697	12,173	13,525	13,654	13,656	12,316	10,276	8,973	8,786	7,915	8,736	0	0	0
Revenue
448,159	439,107	430,676	419,398	408,955	399,472	387,612	368,622	325,391	286,776	248,990	221,022	215,573	208,332	201,149	191,586	183,718	178,513	175,392	175,013	172,851	166,578	156,030	144,791	134,245	129,501	123,436	119,012	0	0	0
Cost of revenue:
Healthcare
-	-	-	-	-	-	-	-	-	-	-	-	55,045	-	53,056	52,340	51,678	51,693	52,520	54,959	56,993	54,942	48,575	42,556	36,541	34,179	35,423	36,002	0	0	0
Research
-	-	-	-	-	-	-	-	-	-	-	-	20,711	-	16,628	14,244	13,030	12,728	12,008	11,351	10,843	10,646	11,158	11,291	11,335	11,317	9,200	6,664	0	0	0
Other
-	-	-	-	-	-	-	-	-	-	-	-	0	-	6,787	6,853	7,049	7,535	8,042	8,540	7,972	7,526	6,567	5,658	5,200	4,935	4,140	4,181	0	0	0
Cost of revenue
168,155	164,833	162,373	157,697	151,739	148,986	146,647	141,325	127,882	114,406	98,009	86,244	83,841	78,882	76,471	73,437	71,757	71,956	72,570	74,850	75,808	73,114	66,300	59,505	53,076	50,431	48,763	46,847	0	0	0
Gross profit
280,004	274,274	268,303	261,701	257,216	250,486	240,965	227,297	197,509	172,370	150,981	134,778	131,732	129,450	124,678	118,149	111,961	106,557	102,822	100,163	97,043	93,464	89,730	85,286	81,169	79,070	74,673	72,165	0	0	0
Operating expenses:
General and administrative
124,367	120,093	115,796	112,470	110,624	109,736	109,165	108,160	93,785	82,983	70,903	59,436	59,458	55,877	53,359	51,003	48,821	47,882	47,333	46,823	45,756	45,131	41,903	39,875	37,813	36,569	35,533	34,209	0	0	0
Sales and marketing
51,670	50,664	48,121	45,669	43,949	42,849	42,806	42,405	38,961	35,322	32,000	29,299	28,792	28,636	28,882	28,496	28,298	27,936	27,635	28,302	28,548	28,805	28,449	27,858	26,953	26,275	26,213	25,532	0	0	0
Credit loss expense
22,672	21,800	21,674	20,973	22,469	22,200	21,236	19,847	15,388	13,300	11,109	9,836	10,084	9,931	9,075	8,825	8,336	8,047	9,144	8,767	9,337	9,347	8,898	8,457	7,679	7,787	9,056	10,588	0	0	0
Research and development
14,229	13,994	13,281	12,049	11,250	11,206	11,327	12,175	11,957	11,101	10,692	9,552	9,002	8,355	7,838	7,266	6,932	7,111	6,817	7,245	7,572	7,396	7,678	7,583	7,507	7,338	6,543	5,685	0	0	0
Other charges
14,018	15,004	10,938	9,670	12,644	14,659	28,517	35,339	34,782	31,436	17,337	11,582	8,590	8,639	7,445	6,440	5,991	6,063	6,535	6,188	5,978	7,098	6,187	8,219	9,760	7,982	7,561	5,217	0	0	0
Total operating expenses
226,924	221,523	209,832	200,853	200,958	200,672	213,042	217,917	194,864	174,133	142,041	119,705	115,926	111,438	106,599	102,030	98,378	97,039	97,464	97,325	97,191	97,777	93,115	91,992	89,712	85,951	84,906	81,231	0	0	0
Income from operations
53,080	52,751	58,471	60,848	56,258	49,814	27,923	9,380	2,645	-1,763	8,940	15,073	15,806	18,012	18,079	16,119	13,583	9,518	5,358	2,838	-148	-4,313	-3,385	-6,706	-8,543	-6,881	-10,233	-9,066	0	0	0
Other expense:
Other expense:
Interest expense
9,107	9,482	9,805	9,875	10,021	9,429	9,258	8,691	6,399	4,897	3,165	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Gain (Loss) on Extinguishment of Debt
-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on equity method investments
-1,266	-1,298	-259	-248	-139	-246	-320	-372	-428	-384	-371	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other non-operating income/(expense), net
-258	-2,243	-991	-340	124	1,365	490	1,342	-107	-2,809	-2,773	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total other expense, net
-10,631	-13,023	-11,055	-10,463	-10,036	-8,310	-9,088	-8,264	-7,477	-8,633	-6,778	-5,576	-4,817	-2,242	-2,088	-1,849	-1,655	-1,622	-1,862	-1,764	-4,912	-7,793	0	0	0	-	-	-	-	0	0
Interest and other loss, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-	-
Income before income taxes
42,449	39,728	47,416	50,385	46,222	41,504	18,835	1,116	-4,832	-10,396	2,162	9,497	10,989	15,770	15,991	14,270	11,928	7,896	3,496	1,074	-5,060	-12,106	-10,548	-13,673	-11,984	-7,104	-10,439	-9,136	0	0	0
(Provision for)/benefit from income taxes
17,184	9,884	8,772	3,972	-2,328	-370	3,836	4,701	7,471	6,747	-37,644	-37,068	-38,547	-37,667	154	150	334	468	570	655	680	-2,313	-2,599	0	0	-	0	-	-	-	0
Net income
25,268	29,844	38,661	46,379	48,523	41,874	14,980	-3,585	-12,303	-17,143	3,553	0	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss attributable to noncontrolling interests
-	-	0	0	-	-946	-1,854	-2,133	-2,133	-1,187	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net Income (Loss) Available to Common Stockholders, Basic
-	-	38,661	46,379	-	42,820	16,834	-1,452	-10,170	-15,956	40,085	46,565	49,536	53,437	15,837	14,120	11,594	-	2,926	419	-5,740	-9,793	0	0	0	-	-	-	-	0	0
Other comprehensive income/(loss):
Foreign currency translation loss
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-2	-151	1	-12	0	0	0	-	-	-	-	-	-	-	-	-	-
Unrealized holding gains/(losses) arising during the period
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0
Comprehensive income/(loss) attributable to BioTelemetry, Inc.
-	-	-	-	-	-	-	-	-	-	-	-	-	-	15,835	13,969	11,595	7,416	4,543	-1,924	0	-	0	0	-	-7,319	0	0	0	-	0
Net income per common share:
Basic (in dollars per share)
0.21	0.04	0.24	0.25	0.35	0.33	0.48	0.32	0.18	-0.53	-0.07	0.06	0.01	1.44	0.15	0.17	0.15	0.10	0.09	0.08	0.00	-	0.00	-0.15	-	-	-	-	-	-	-
Diluted (in dollars per share)
0.19	0.04	0.23	0.23	0.32	0.29	0.45	0.29	0.17	-0.52	-0.07	0.05	0.01	1.32	0.14	0.15	0.14	0.10	0.08	0.08	0.00	-	0.00	-0.15	-	-	-	-	-	-	-
Basic and diluted (in dollars per share)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.16	-	-0.12	-0.09	-0.08	-0.12	-0.05
Weighted average number of common shares outstanding:
Basic (in shares)
34,186	34,405	33,908	33,825	33,654	32,828	33,003	32,435	32,570	32,531	31,897	28,687	28,429	28,246	28,102	27,960	27,370	27,276	27,181	27,071	26,934	-	26,521	26,434	-	-	-	-	-	-	-
Dilutive common stock equivalents (in shares)
2,403	2,363	2,360	2,493	2,752	3,573	2,915	3,143	2,665	-5,872	0	2,986	2,886	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Diluted (in shares)
36,589	36,768	36,268	36,318	36,406	36,401	35,918	35,578	35,235	26,659	31,897	31,673	31,315	31,037	30,880	30,516	29,521	31,192	29,311	28,918	26,934	-	26,521	26,434	-	-	-	-	-	-	-
Basic and diluted (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	26,110	-	25,616	25,537	25,190	24,995	24,918
Anti-dilutive stock options and restricted stock units excluded from weighted average calculation (in shares)
-	-	-	-	-	-	-	-	-	-	-	-	496	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-